KALV: Volume dana dhuwit perusahaan KalVista Pharmaceuticals, Inc.

Lambang korporat lan logo KalVista Pharmaceuticals (KALV)

Currently in the clinical testing phase, KalVista Pharmaceuticals (KALV) incurs significant R&D expenses, which temporarily limits margins. KalVista Pharmaceuticals (KALV) is developing unique oral inhibitors for the therapy of rare pathologies, replacing injections with tablets. The company's cash position reflects its actual resilience to shocks, where 0.27 expresses the current value of the metric. The strategy is based on capturing the HAE market by improving patient comfort.

Aset likuid perusahaan: KalVista Corp (KALV) kanggo 04.07.2022 - 21.06.2026

Rincian analitis perusahaan KalVista Pharmaceuticals

Produk merek KalVista Pharma

KalVista Pharmaceuticals (KALV) preparation for the market launch of its flagship drug requires strict liquidity control, meaning that daily monitoring of the company's cash reserves allows for an accurate assessment of the balance sheet's financial resilience. This metric captures the actual cash balance, where steady growth confirms the absence of credit risks, while excessive accumulation may signal inefficient capital management.

Analisis pesaing KalVista Pharmaceuticals

Volume dana dhuwit perusahaan ARGX|BioNTech - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan ABVX (abivax.com)|Sisa dhuwit perusahaan ADMA|Protagonist Therapeutics, Inc. - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Immunovant, Inc.|KNSA: Volume dana dhuwit perusahaan|GRFS - Aset likuid perusahaan|ADPT (Adaptive Biotechnologies Inc.) - Volume dana dhuwit perusahaan|CLDX: Sisa dhuwit perusahaan|Dana dhuwit perusahaan Aurinia Pharmaceuticals Inc. (AUPH)|Dana dhuwit perusahaan BCRX (BioCryst Pharmaceuticals Inc)|Volume dana dhuwit perusahaan VERA (Vera Corp)|Gunggung dana dhuwit perusahaan DNTH (Dianthus Therapeutics)|PHVS - Dana dhuwit perusahaan|ABCL: Dana dhuwit perusahaan|TRML: Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Precigen, Inc.|Dhuwit awis perusahaan PHAR|Nektar Therapeutics - Total volume dana dhuwit perusahaan|Dana dhuwit perusahaan Upstream Bio Corp (UPB)|Dhuwit awis perusahaan Zenas Biopharma ZBIO|Dana dhuwit perusahaan Immunome Bio IMNM|GOSS: Dhuwit awis lan setara dhuwit awis perusahaan|SEPN - Dana dhuwit perusahaan|PVLA - Volume dana dhuwit perusahaan|SVRA: Volume dana dhuwit perusahaan|RIGL - Aset likuid perusahaan|ANAB (AnaptysBio Inc) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Astria Corp (ATXS)|Volume dana dhuwit perusahaan ENGN|Aset likuid perusahaan rapt.com|Volume dana dhuwit perusahaan JBIO (Aerovate Therapeutics Inc)|Aset likuid perusahaan Aclaris Therapeutics, Inc. (ACRS)|KYTX - Dana dhuwit perusahaan|Aset likuid perusahaan Tiziana Life Sciences TLSA|CABA: Volume dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan VTYX|Dhuwit awis perusahaan THTX|Volume dana dhuwit perusahaan Avalo Therapeutics Inc.|Dana dhuwit perusahaan Eledon (ELDN)|Volume dana dhuwit perusahaan Agenus Inc (AGEN)|Volume dana dhuwit perusahaan CLYM (climbbio.com)|ZURA - Dhuwit awis perusahaan|atyrpharma.com - Volume dana dhuwit perusahaan|ADAG (adagene.com) - Dhuwit awis lan setara dhuwit awis perusahaan|IMA (Ikena Oncology) - Dhuwit awis perusahaan|Dhuwit awis perusahaan Shattuck Labs Inc|EQ (Equillium Inc) - Volume dana dhuwit perusahaan|CNTB: Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan IMUX|ATRA (Atara Biotherapeutics, Inc.) - Sisa dhuwit perusahaan|Volume dana dhuwit perusahaan IFRX (inflarx.de)|X4 Pharmaceuticals - Dana dhuwit perusahaan|Adicet Bio, Inc. - Volume dana dhuwit perusahaan|CELU (celularity.com) - Dhuwit awis lan setara dhuwit awis perusahaan|INMB: Volume dana dhuwit perusahaan|Barinthus Biotherapeutics PLC (BRNS) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Kezar Life Sciences|Dhuwit awis perusahaan SAB Biotherapeutics (SABS)|Dana dhuwit perusahaan Akari Therapeutics Plc (AKTX)|Dhuwit awis perusahaan Enlivex Therapeutics, Ltd. ENLV|Q32 Bio Inc. - Dhuwit awis perusahaan|GeoVax Labs (GOVX) - Cadangan dhuwit perusahaan|edesabiotech.com - Volume dana dhuwit perusahaan|Aset likuid perusahaan iBio Corp IBIO|CARM: Volume dana dhuwit perusahaan|xtlbio.com (XTLB) - Volume dana dhuwit perusahaan|BOLT (Bolt Biotherapeutics) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan HCW Biologics (HCWB)|Dhuwit awis perusahaan APVO (Aptevo Therapeutics)|AIM - Cadangan dhuwit perusahaan|Aditxt - Dhuwit awis perusahaan|Posisi dhuwit perusahaan gribio.com|XRTX: Dhuwit awis perusahaan|Sisa dhuwit perusahaan HIND (Vyome Holdings)|REVB (Revelation Bio) - Dhuwit awis perusahaan|Indaptus Corp (INDP) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan scinai.com|Dhuwit awis perusahaan CalciMedica, Inc. (CALI)|Dana dhuwit perusahaan Affimed NV (AFMD)|Dana dhuwit perusahaan ALLK (Allakos Inc)|Dana dhuwit perusahaan HOOKIPA Pharma, Inc. HOOK|Aset likuid perusahaan IGM Bio (IGMS)|iTeos Pharma - Volume dana dhuwit perusahaan|Aset likuid perusahaan oceanbiomedical.com OCEA|TC BioPharm (TCBP) - Dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan THRD